Alpha(1)-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation

Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1471-80. doi: 10.1152/ajpheart.00232.2002.

Abstract

The possible involvement of different kinases in the alpha(1)-adrenoreceptor (AR)-mediated positive inotropic effect (PIE) was investigated in rat papillary muscle and compared with beta-AR-, endothelin receptor- and phorbol ester-induced changes in contractility. The alpha(1)-AR-induced PIE was not reduced by the inhibitors of protein kinase C (PKC), MAPK (ERK and p38), phosphatidyl inositol 3-kinase, or calmodulin kinase II. However, PKC inhibition attenuated the effect of phorbol 12-myristate 13-acetate (PMA) on contractility. alpha(1)-AR-induced PIE was reduced by approximately 90% during inhibition of myosin light chain kinase (MLCK) by 1-(5-chloronaphthalene-1-sulfonyl)1H-hexahydro-1,4-diazepine (ML-9). Endothelin-induced PIE was also reduced by ML-9, but ML-9 had no effect on beta-AR-induced PIE. The Rho kinase inhibitor Y-27632 also reduced the alpha(1)-AR-induced PIE. The alpha(1)-AR-induced PIE in muscle strips from explanted failing human hearts was also sensitive to MLCK inhibition. alpha(1)-AR induced a modest increase in (32)P incorporation into myosin light chain in isolated rat cardiomyocytes. This effect was eliminated by ML-9. The PIE of alpha(1)-AR stimulation seems to be dependent on MLCK phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azepines / pharmacology
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism
  • Carcinogens / pharmacology
  • Cardiotonic Agents / pharmacology*
  • Endothelin-1 / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Humans
  • In Vitro Techniques
  • Intracellular Signaling Peptides and Proteins
  • Isoproterenol / pharmacology*
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology
  • Myosin Light Chains / antagonists & inhibitors
  • Myosin Light Chains / metabolism*
  • Papillary Muscles / drug effects
  • Papillary Muscles / enzymology*
  • Phenylephrine / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism
  • Rats
  • Receptors, Adrenergic, alpha-1 / metabolism*
  • Receptors, Endothelin / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology
  • rho-Associated Kinases

Substances

  • Azepines
  • Carcinogens
  • Cardiotonic Agents
  • Endothelin-1
  • Enzyme Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • Myosin Light Chains
  • Phosphoinositide-3 Kinase Inhibitors
  • Receptors, Adrenergic, alpha-1
  • Receptors, Endothelin
  • ML 9
  • Phenylephrine
  • Protein Serine-Threonine Kinases
  • rho-Associated Kinases
  • Protein Kinase C
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Isoproterenol
  • Tetradecanoylphorbol Acetate